BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 29212455)

  • 1. Comparative gene co-expression network analysis of epithelial to mesenchymal transition reveals lung cancer progression stages.
    Wang D; Haley JD; Thompson P
    BMC Cancer; 2017 Dec; 17(1):830. PubMed ID: 29212455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial-mesenchymal transition markers screened in a cell-based model and validated in lung adenocarcinoma.
    Song J; Wang W; Wang Y; Qin Y; Wang Y; Zhou J; Wang X; Zhang Y; Wang Q
    BMC Cancer; 2019 Jul; 19(1):680. PubMed ID: 31296175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptome profiling reveals novel gene expression signatures and regulating transcription factors of TGFβ-induced epithelial-to-mesenchymal transition.
    Du L; Yamamoto S; Burnette BL; Huang D; Gao K; Jamshidi N; Kuo MD
    Cancer Med; 2016 Aug; 5(8):1962-72. PubMed ID: 27318801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying global expression patterns and key regulators in epithelial to mesenchymal transition through multi-study integration.
    Parsana P; Amend SR; Hernandez J; Pienta KJ; Battle A
    BMC Cancer; 2017 Jun; 17(1):447. PubMed ID: 28651527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition.
    Mak MP; Tong P; Diao L; Cardnell RJ; Gibbons DL; William WN; Skoulidis F; Parra ER; Rodriguez-Canales J; Wistuba II; Heymach JV; Weinstein JN; Coombes KR; Wang J; Byers LA
    Clin Cancer Res; 2016 Feb; 22(3):609-20. PubMed ID: 26420858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells.
    Shukla P; Vogl C; Wallner B; Rigler D; Müller M; Macho-Maschler S
    BMC Genomics; 2015 Nov; 16():944. PubMed ID: 26572553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for embryonic stem-like signature and epithelial-mesenchymal transition features in the spheroid cells derived from lung adenocarcinoma.
    Roudi R; Madjd Z; Ebrahimi M; Najafi A; Korourian A; Shariftabrizi A; Samadikuchaksaraei A
    Tumour Biol; 2016 Sep; 37(9):11843-11859. PubMed ID: 27048287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial-mesenchymal transition.
    Lin SH; Wang J; Saintigny P; Wu CC; Giri U; Zhang J; Menju T; Diao L; Byers L; Weinstein JN; Coombes KR; Girard L; Komaki R; Wistuba II; Date H; Minna JD; Heymach JV
    BMC Genomics; 2014 Dec; 15(1):1079. PubMed ID: 25486910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA LINC01186, regulated by TGF-β/SMAD3, inhibits migration and invasion through Epithelial-Mesenchymal-Transition in lung cancer.
    Hao Y; Yang X; Zhang D; Luo J; Chen R
    Gene; 2017 Apr; 608():1-12. PubMed ID: 28119085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combinatorially regulated RNA splicing signature predicts breast cancer EMT states and patient survival.
    Qiu Y; Lyu J; Dunlap M; Harvey SE; Cheng C
    RNA; 2020 Sep; 26(9):1257-1267. PubMed ID: 32467311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-146a inhibits epithelial mesenchymal transition in non-small cell lung cancer by targeting insulin receptor substrate 2.
    Park DH; Jeon HS; Lee SY; Choi YY; Lee HW; Yoon S; Lee JC; Yoon YS; Kim DS; Na MJ; Kwon SJ; Kim DS; Kang J; Park JY; Son JW
    Int J Oncol; 2015 Oct; 47(4):1545-53. PubMed ID: 26238771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-resistant CXCR4-positive cells have the molecular characteristics of EMT in NSCLC.
    Yin H; Wang Y; Chen W; Zhong S; Liu Z; Zhao J
    Gene; 2016 Dec; 594(1):23-29. PubMed ID: 27581786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene.
    Li Y; Zhang H; Li Y; Zhao C; Fan Y; Liu J; Li X; Liu H; Chen J
    Mol Carcinog; 2018 Jan; 57(1):125-136. PubMed ID: 28940757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinatorial perturbation analysis reveals divergent regulations of mesenchymal genes during epithelial-to-mesenchymal transition.
    Watanabe K; Panchy N; Noguchi S; Suzuki H; Hong T
    NPJ Syst Biol Appl; 2019; 5():21. PubMed ID: 31275609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPOCK1 is a novel transforming growth factor-β target gene that regulates lung cancer cell epithelial-mesenchymal transition.
    Miao L; Wang Y; Xia H; Yao C; Cai H; Song Y
    Biochem Biophys Res Commun; 2013 Nov; 440(4):792-7. PubMed ID: 24134845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients.
    Tan TZ; Miow QH; Miki Y; Noda T; Mori S; Huang RY; Thiery JP
    EMBO Mol Med; 2014 Oct; 6(10):1279-93. PubMed ID: 25214461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the TGFβ-induced program in primary airway epithelial cells shows essential role of NF-κB/RelA signaling network in type II epithelial mesenchymal transition.
    Tian B; Li X; Kalita M; Widen SG; Yang J; Bhavnani SK; Dang B; Kudlicki A; Sinha M; Kong F; Wood TG; Luxon BA; Brasier AR
    BMC Genomics; 2015 Jul; 16(1):529. PubMed ID: 26187636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
    Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
    Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancer.
    Nurwidya F; Takahashi F; Kobayashi I; Murakami A; Kato M; Minakata K; Nara T; Hashimoto M; Yagishita S; Baskoro H; Hidayat M; Shimada N; Takahashi K
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):332-8. PubMed ID: 25446090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Correlation Between the Immune and Epithelial-Mesenchymal Transition Signatures Suggests Potential Therapeutic Targets and Prognosis Prediction Approaches in Kidney Cancer.
    Liang J; Liu Z; Zou Z; Tang Y; Zhou C; Yang J; Wei X; Lu Y
    Sci Rep; 2018 Apr; 8(1):6570. PubMed ID: 29700419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.